Skip to main content

Mutual Fund Review: Reliance Pharma

Investors looking to take a plunge in pharma space can consider Reliance Pharma given its diversified portfolio & healthy performance

 

RECKONED as a laggard till one-andhalf-year ago, the pharmaceuticals sector is now one of the front line stocks on the bourses. Over the past one year, pharmaceutical funds has rewarded investors with an average of about 88% returns, emerging as a top performer amongst all other sectoral or theme funds.


   And within the pharmaceutical funds category, Reliance Pharma has emerged as one of the top performers, consistently over a period of time. Launched in May 2004, the fund is in fact the last entrant in the category that comprises just about four similar funds — one each from UTI, Franklin Templeton and SBI Magnum.

PERFORMANCE:

Benchmarked to BSE Healthcare (HC) index, Reliance Pharma has consistently beaten its benchmark since the time of its launch – except for the year 2008 when it marginally underperformed BSE HC.


   Tracking its historic performance, the fund returned about 29% in 2005 even as BSE HC returned just about 1.8% in that year. And though the pharmaceutical sector was an underperformer in the year 2007 — the most bullish years of the decade, Reliance Pharma's relatively aggressive investment tactics helped it clock about 50% gains in that year against BSE HC's 16.5% then. The average returns by the category of pharmaceutical funds had stood at about 17% that year.


   In 2008, however, the decline of about 34% in the net asset value (NAV) of Reliance Pharma turned out to be sharper than that of BSE HC, which declined by about 33% that year. Those invested in the defensive pharmaceutical space may not have clocked in extremely handsome gains in 2007. But then they were equally well-off in the meltdown year which saw the major indices and the diversified equity schemes decline by over 50%. And given the rally in the pharmaceutical space last year (2009), those invested in the pharmaceutical space, especially in Reliance Pharma, have had ample reasons to rejoice.


   Even as BSE HC returned about 69% last year, the returns of Reliance Pharma soared by more than 118% beating even the Sensex and the Nifty returns of about 81% and 76%, respectively. Continuing its winning streak in the current calendar year, Reliance Pharma has returned about 11% since January this year against BSE HC's 5% returns during this period.


   The Sensex and the Nifty, given their extremely low weightages of about 1.3% and 2.4%, respectively in the pharmaceutical sector, have in fact generated negative returns of about 6% each till date in the current calendar year.

PORTFOLIO:

Unlike most other funds from the Reliance basket, which have preferences for high cash, especially in market volatilities, Reliance Pharma has sailed through the market tides with bare minimum levels of cash. The fund has held an average of just about 5.4% cash in the portfolio for over three years now. As far as its stock-holdings are concerned, currently its assets under management (AUM) worth Rs 360 crore is well diversified to about 18 stocks with exposure per stock restricted to about 8-9%. However, its bias to invest in the mid and small-cap space makes it relatively aggressive player in the pharmaceutical space.


   As this fund continues to hold many of its stocks for over three years now, it has made handsome gains on these holdings given the rally in the pharmaceutical space in the past year and a half. These include stocks like Aurobindo Pharma, Aventis Pharma, Divi's Labs and Sun Pharma.


   However, it is Zydus Wellness, which can be called the pick of the year for fund. Since the time Reliance Pharma has invested into this stock in April 2009, the stock has jumped by more than 500% till date. Its investment in Zydus Wellness currently account for nearly 6% of its AUM. As such, if one were to analyse the profitability quotient of Reliance Pharma's current portfolio, 100% of its equity holdings are currently in the profit zone.

OUR VIEW:

The popular maxim, patience pays, definitely holds true for the pharma investors, which has seen a dramatic turnaround in the past one-anda-half years. However, whether this rally in the pharma space continue in future is anyone's guess! As such, restricting ones investment to just a single sector calls for a great deal of caution and a high-risk appetite. And this risk appetite needs to be enhanced further in case of Reliance Pharma, given its high exposure to the small and mid-cap companies, which increases its beta as well as the risk quotient. But, given its well-diversified portfolio and healthy performance record, those willing to take a plunge in the pharma space can consider this fund.

 


Popular posts from this blog

Am you Required to E-file Tax Return?

Download Tax Saving Mutual Fund Application Forms Invest In Tax Saving Mutual Funds Online Buy Gold Mutual Funds Leave a missed Call on 94 8300 8300   Am I Required to 'E-file' My Return? Yes, under the law you are required to e-file your return if your income for the year is Rs. 500,000 or more. Even if you are not required to e-file your return, it is advisable to do so for the following benefits: i) E-filing is environment friendly. ii) E-filing ensures certain validations before the return is filed. Therefore, e-returns are more accurate than the paper returns. iii) E-returns are processed faster than the paper returns. iv) E-filing can be done from the comfort of home/office and you do not have to stand in queue to e-file. v) E-returns can be accessed anytime from the tax department's e-filing portal. For further information contact Prajna Capit...

Mutual Fund Review: HDFC Index Sensex Plus

  In terms of size, HDFC Index Sensex Plus may be one of the smallest offerings from the HDFC stable. But that has not dampened its show, which has beaten the Sensex by a mile in overall returns   HDFC Index Sensex Plus is a passively managed diversified equity scheme with Sensex as its benchmark index. The fund also invests a small proportion of its equity portfolio in non-Sensex scrips. The scheme cannot boast of an impressive size and is one of the smallest in the HDFC basket with assets under management (AUM) of less than 60 crore. PERFORMANCE: Being passively managed and portfolio aligned to that of the benchmark, the performance of the index fund is expected to follow that of the benchmark and in this respect, it has not disappointed investors. Since its launch in July 2002, the fund has outperformed Sensex in overall returns by good margins.    While every 1,000 invested in HDFC Index Sensex Plus in July 2002 is worth 6,130 now, a similar amount invested in Sensex then wo...

IDFC - Long term infrastructure bonds - Tranche 2

IDFC - Long term infrastructure bonds What are infrastructure bonds? In 2010, the government introduced a new section 80CCF under the Income Tax Act, 1961 (" Income Tax Act ") to provide for income tax deductions for subscription to long-term infrastructure bonds and pursuant to that the Central Board of Direct Taxes passed Notification No. 48/2010/F.No.149/84/2010-SO(TPL) dated July 9, 2010. These long term infrastructure bonds offer an additional window of tax deduction of investments up to Rs. 20,000 for the financial year 2010-11. This deduction is over and above the Rs 1 lakh deduction available under sections 80C, 80CCC and 80CCD read with section 80CCE of the Income Tax Act. Infrastructure bonds help in intermediating the retail investor's savings into infrastructure sector directly. Long term infrastructure Bonds by IDFC IDFC issued an earlier tranche of these long term infrastructure bonds on November 12, 2010. This is the second public issue of long-te...

National Savings Certificate

National Savings Certificate Here's everything you need to know about the 5-year savings scheme offered by the Government This is a 5-year small savings scheme of the government. From 1 July 2016, a National Savings Certificate (NSC) can be held in the electronic mode too. Physical pre-printed NSC certificates have been discontinued and replaced with Public Provident Fund-like passbooks. What's on offer The minimum amount you can invest in them is Rs100 and there is no upper limit. Under this scheme, all deposits up to Rs1.5 lakh qualify for deduction under section 80C of the Income-tax Act, 1961. The interest earned is taxable. You can invest in multiples of Rs 100. These certificates can be owned individually, jointly and also on behalf of minors. The interest rates for all small savings schemes are released on a quarterly basis. The effective rate for NSC from 1 October to 31 December is 8%. The interest is calculated on an annual compounding basis and is given along w...

Different types of Mutual Funds

You may not be comfortable investing in the stock market. It might not seem like your cup of tea. But you can start by investing in Mutual Funds. Many first-time investors invest in Mutual Funds. This is because they do not know how to invest in individual securities. Basic information on Mutual Funds People invest their money in stocks, bonds, and other securities through Mutual Funds. Each Fund has different schemes with specific objectives. Professional Fund Managers look after these schemes. Your Fund Manager could help you invest in a scheme that suits your financial goal. Functioning of Mutual Funds You could make money through Mutual Funds in different ways. A single Mutual Fund could hold many different stocks, bonds, and debentures. This minimizes the risk by spreading out your investment. You could earn dividends from stocks and interest from bonds. You could also earn capital by selling securities when their price increases. Usually, you could choose to sell your share any t...
Related Posts Plugin for WordPress, Blogger...
Invest in Tax Saving Mutual Funds Download Any Applications
Transact Mutual Funds Online Invest Online
Buy Gold Mutual Funds Invest Now